Related references
Note: Only part of the references are listed.Exosomal miRNAs-a diagnostic biomarker acting as a guiding light in the diagnosis of prostate cancer
Sougata Ghosh Chowdhury et al.
FUNCTIONAL & INTEGRATIVE GENOMICS (2023)
A sensitive ?turn-on? fluorescent biosensor for the detection of biomarkers based on three-dimensional DNA walker
Yunyan Xie et al.
TALANTA (2023)
An ultrasensitive split-type electrochemical immunosensor based on controlled-release strategy for detection of CA19-9
Bing Li et al.
BIOSENSORS & BIOELECTRONICS (2023)
Gold nanoparticle assimilated polymer layer on carbon nanotube matrices for sensitive detection of serotonin in presence of dopamine in-vitro
Kummari Shekher et al.
INORGANICA CHIMICA ACTA (2023)
Self-activation of symbiotic multi-DNA machines transducing exponentially amplified fluorescence for ultrasensitively signaling of terminal deoxynucleotidyl transferase activity
Yubo Peng et al.
SENSORS AND ACTUATORS B-CHEMICAL (2023)
An ultrasensitive carcinoembryonic antigen electrochemical aptasensor based on 3D DNA nanoprobe and Exo III
Yanli Ji et al.
BIOSENSORS & BIOELECTRONICS (2022)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Novel Diagnostic Biomarkers in Colorectal Cancer
Aneta L. Zygulska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Crystal structure of a human MUC16 SEA domain reveals insight into the nature of the CA125 tumor marker
Brandy White et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2022)
Low-Grade Serous Carcinoma of the Ovary: The Current Status
Abdulaziz Babaier et al.
DIAGNOSTICS (2022)
Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study
Shinya Abe et al.
BMC CANCER (2022)
Association of the COVID-19 Pandemic With Patterns of Statewide Cancer Services
K. Robin Yabroff et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)
Dual-template rectangular nanotube molecularly imprinted polypyrrole for label-free impedimetric sensing of AFP and CEA as lung cancer biomarkers
Navid Taheri et al.
TALANTA (2022)
Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
Ke Ye et al.
FRONTIERS IN ONCOLOGY (2022)
Poly(Thionine)-Modified Screen-Printed Electrodes for CA 19-9 Detection and Its Properties in Raman Spectroscopy
Yuselis Castano-Guerrero et al.
CHEMOSENSORS (2022)
Magnetic antifouling material based ratiometric electrochemical biosensor for the accurate detection of CEA in clinical serum
Huiqing Yang et al.
BIOSENSORS & BIOELECTRONICS (2022)
CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3
Lucas Porras et al.
CANCERS (2022)
The Effect of Older Age and Frailty on the Time to Diagnosis of Cancer: A Connected Bradford Electronic Health Records Study
Charlotte Summerfield et al.
CANCERS (2022)
Prognostic value of epithelial-mesenchymal transition circulating tumor cells in female breast cancer: A meta-analysis
Qiang Zhao et al.
FRONTIERS IN ONCOLOGY (2022)
Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling
Shinji Kohsaka et al.
NPJ PRECISION ONCOLOGY (2022)
Molecular Biomarkers in Cancer
Virinder Kaur Sarhadi et al.
BIOMOLECULES (2022)
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers
Michela Chianca et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Diagnostic impact of CEA and CA 15-3 on monitoring chemotherapy of breast cancer patients
Diya Hasan
Journal of Circulating Biomarkers (2022)
Liquid biopsy: current technology and clinical applications
Mina Nikanjam et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
From the patient to the population: Use of genomics for population screening
Chloe Mighton et al.
FRONTIERS IN GENETICS (2022)
Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients
Budi Darmawan et al.
WORLD JOURNAL OF NUCLEAR MEDICINE (2022)
Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study
Jin Liu et al.
BREAST JOURNAL (2022)
Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening
Mohamed Badheeb et al.
CURRENT ONCOLOGY (2022)
Cancer vaccines: the next immunotherapy frontier
Matthew J. Lin et al.
NATURE CANCER (2022)
Technological advances in electrochemical biosensors for the detection of disease biomarkers
Jae Hyun Kim et al.
BIOMEDICAL ENGINEERING LETTERS (2021)
Fluorescence sensing strategy based on aptamer recognition and mismatched catalytic hairpin assembly for highly sensitive detection of alpha-fetoprotein
Shengqiang Li et al.
ANALYTICA CHIMICA ACTA (2021)
Blueprint for cancer research: Critical gaps and opportunities
Lynne W. Elmore et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Double Stopband Bilayer Photonic Crystal Based Upconversion Fluorescence PSA Sensor
Songtao Hu et al.
SENSORS AND ACTUATORS B-CHEMICAL (2021)
Dual assaying of breast cancer biomarkers by using a sandwich-type electrochemical aptasensor based on a gold nanoparticles-3D graphene hydrogel nanocomposite and redox probes labeled aptamers
Zahra Shekari et al.
SENSORS AND ACTUATORS B-CHEMICAL (2021)
A novel aptasensor based on HCR and G-quadruplex DNAzyme for fluorescence detection of Carcinoembryonic Antigen
Yunfeng Bai et al.
TALANTA (2021)
Early detection of gastric cancer beyond endoscopy- new methods
Marcis Leja et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2021)
Impedimetric aptamer-based glycan PSA score for discrimination of prostate cancer from other prostate diseases
Ana Diaz-Fernandez et al.
BIOSENSORS & BIOELECTRONICS (2021)
Carbohydrate antigen 19-9 electrochemical immunosensor based on 1D-MoS2 nanorods/LiNb3O8 and polyoxometalate-incorporated gold nanoparticles
Mehmet Lutfi Yola et al.
MICROCHEMICAL JOURNAL (2021)
A fluorescent biosensor based on prismatic hollow Metal-polydopamine frameworks and 6-carboxyfluorescein (FAM)-labeled protein aptamer for CA15-3 detection
Yawen Wu et al.
SENSORS AND ACTUATORS B-CHEMICAL (2021)
Functionalized SERS substrate based on silicon nanowires for rapid detection of prostate specific antigen
Awatef Ouhibi et al.
SENSORS AND ACTUATORS B-CHEMICAL (2021)
A novel biosensor for the ultrasensitive detection of the lncRNA biomarker MALAT1 in non-small cell lung cancer
Mei Chen et al.
SCIENTIFIC REPORTS (2021)
New Predictive Biomarkers for Ovarian Cancer
Ghofraan Abdulsalam Atallah et al.
DIAGNOSTICS (2021)
Antifouling Peptide Hydrogel Based Electrochemical Biosensors for Highly Sensitive Detection of Cancer Biomarker HER2 in Human Serum
Wenqi Wang et al.
ANALYTICAL CHEMISTRY (2021)
Electrochemical diagnostics of infectious viral diseases: Trends and challenges
K. Yugender Goud et al.
BIOSENSORS & BIOELECTRONICS (2021)
Spatially-resolved dual-potential sandwich electrochemiluminescence immunosensor for the simultaneous determination of carbohydrate antigen 19-9 and carbohydrate antigen 24-2
Guichun Mo et al.
BIOSENSORS & BIOELECTRONICS (2021)
Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation
Ningning Wang et al.
BIOENGINEERED (2021)
Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei
Lei Liang et al.
FRONTIERS IN ONCOLOGY (2021)
2D/3D material amplification strategy for disposable label-free electrochemical immunosensor based on rGO-TEPA@Cu-MOFs@SiO2@AgNPs composites for NMP22 detection
Shengzhong Rong et al.
MICROCHEMICAL JOURNAL (2021)
CA125-Tn ELISA assay improves specificity of pre-operative diagnosis of ovarian cancer among patients with elevated serum CA125 levels
Yi-Sheng Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia
Allison J. Kaeding et al.
BLOOD ADVANCES (2021)
Identification of Novel Biomarkers and Candidate Drug in Ovarian Cancer
Chia-Jung Li et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Quartz Crystal Microbalance (QCM) Based Biosensor Functionalized by HER2/neu Antibody for Breast Cancer Cell Detection
Merve Yilmaz et al.
CHEMOSENSORS (2021)
Electrochemistry-Assisted Surface Plasmon Resonance Biosensor for Detection of CA 15-3
Jose A. Ribeiro et al.
ANALYTICAL CHEMISTRY (2021)
Engineering paper-based visible light-responsive Sn-self doped domed SnO2 nanotubes for ultrasensitive photoelectrochemical sensor
Haihan Yu et al.
BIOSENSORS & BIOELECTRONICS (2021)
Molecular and Circulating Biomarkers of Brain Tumors
Wojciech Jelski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A simple label-free electrochemical sensor for sensitive detection of alpha-fetoprotein based on specific aptamer immobilized platinum nanoparticles/carboxylated-graphene oxide
Jantima Upan et al.
SCIENTIFIC REPORTS (2021)
Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction
Simona Ferraro et al.
CANCERS (2021)
Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis
Gang Chen et al.
BIOENGINEERED (2021)
Determining breast cancer biomarker status and associated morphological features using deep learning
Paul Gamble et al.
COMMUNICATIONS MEDICINE (2021)
Identification of Novel Biomarkers Associated With the Prognosis and Potential Pathogenesis of Breast Cancer via Integrated Bioinformatics Analysis
Meng Wu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
Earlier diagnosis: the importance of cancer symptoms
Katriina Whitaker
LANCET ONCOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial
Robert Coleman et al.
LANCET ONCOLOGY (2020)
A biosensor for determination of the circulating biomarker CA125/MUC16 by Surface Plasmon Resonance Imaging
B. Szymanska et al.
TALANTA (2020)
Prognostic value of neuron-specific enolase for small cell lung cancer: a systematic review and meta-analysis
Zhoujunyi Tian et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
An eco-friendly MIP-solid surface fluorescence immunosensor for detection of CA 19-9 tumor marker using Ni nanocluster as an emitter labels
Delnia Bahari et al.
JOURNAL OF THE IRANIAN CHEMICAL SOCIETY (2020)
Recent Trends in Electrochemical Sensors for Vital Biomedical Markers Using Hybrid Nanostructured Materials
K. Koteshwara Reddy et al.
ADVANCED SCIENCE (2020)
The Evolution of Our Understanding of the Biology of Cancer Is the Key to Avoiding Overdiagnosis and Overtreatment
Kelly Hewitt et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Role of CD25 expression on prognosis of acute myeloid leukemia: A literature review and meta-analysis
Jingyuan Li et al.
PLOS ONE (2020)
Facile Electrochemically Reduced Graphene oxide-Multi-walled Carbon Nanotube Nanocomposite as Sensitive Probe for in-vitro Determination of Nitrofurantoin in Biological Fluids
Shekher Kummari et al.
ELECTROANALYSIS (2020)
Cervical cancer risk profiling: molecular biomarkers predicting the outcome of hrHPV infection
Mariano A. Molina et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2020)
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
Xingdong Chen et al.
NATURE COMMUNICATIONS (2020)
Fluorescence immunoassay based on nitrogen doped carbon dots for the detection of human nuclear matrix protein NMP22 as biomarker for early stage diagnosis of bladder cancer
Hazha Omar Othman et al.
MICROCHEMICAL JOURNAL (2020)
Red-Fluorescent Pt Nanoclusters for Detecting and Imaging HER2 in Breast Cancer Cells
Shin-ichi Tanaka et al.
ACS OMEGA (2020)
Tailored Biofunctionalized Biosensor for the Label-Free Sensing of Prostate-Specific Antigen
Sachin Mishra et al.
ACS APPLIED BIO MATERIALS (2020)
Development of Therapeutic Vaccines for Ovarian Cancer
Stephanie Chow et al.
VACCINES (2020)
A highly sensitive fluorescent immunosensor for sensitive detection of nuclear matrix protein 22 as biomarker for early stage diagnosis of bladder cancer
Hazha Omar Othman et al.
RSC ADVANCES (2020)
A novel ECL sensor based on a boronate affinity molecular imprinting technique and functionalized SiO2@CQDs/AuNPs/MPBA nanocomposites for sensitive determination of alpha-fetoprotein
Guichun Mo et al.
BIOSENSORS & BIOELECTRONICS (2019)
Liquid biopsy in breast cancer: A comprehensive review
Sahar Alimirzaie et al.
CLINICAL GENETICS (2019)
The association of five preoperative serum tumor markers and pathological features in patients with breast cancer
Mingjian Lian et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2019)
A highly sensitive label-free electrochemical immunosensor based on AuNPs-PtNPs-MOFs for nuclear matrix protein 22 analysis in urine sample
Shuang Zhao et al.
JOURNAL OF ELECTROANALYTICAL CHEMISTRY (2019)
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
M. G. Dal Bello et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Employing AgNPs doped amidoxime-modified polyacrylonitrile (PAN-oxime) nanofibers for target induced strand displacement-based electrochemical aptasensing of CA125 in ovarian cancer patients
Leila Farzin et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Molecularly imprinted polymer SPE sensor for analysis of CA-125 on serum
Tania S. C. R. Rebelo et al.
ANALYTICA CHIMICA ACTA (2019)
Construction of Tb-MOF-on-Fe-MOF conjugate as a novel platform for ultrasensitive detection of carbohydrate antigen 125 and living cancer cells
Minghua Wang et al.
BIOSENSORS & BIOELECTRONICS (2019)
A 2D transition metal carbide MXene-based SPR biosensor for ultrasensitive carcinoembryonic antigen detection
Qiong Wu et al.
BIOSENSORS & BIOELECTRONICS (2019)
Electrochemical Sensing Platforms for HER2-ECD Breast Cancer Biomarker Detection
Maria Freitas et al.
ELECTROANALYSIS (2019)
Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer
Xinyu Mei et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2019)
A label-free immunosensor for the detection of nuclear matrix protein-22 based on a chrysanthemum-like Co-MOFs/CuAu NWs nanocomposite
Siyuan Li et al.
ANALYST (2019)
Cancer prevention and screening: the next step in the era of precision medicine
Holli A. Loomans-Kropp et al.
NPJ PRECISION ONCOLOGY (2019)
Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors
Chiara Casadei et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Ultrasensitive flexible FET-type aptasensor for CA 125 cancer marker detection based on carboxylated multiwalled carbon nanotubes immobilized onto reduced graphene oxide film
Samira Mansouri Majd et al.
ANALYTICA CHIMICA ACTA (2018)
Polycytosine DNA Electric-Current-Generated Immunosensor for Electrochemical Detection of Human Epidermal Growth Factor Receptor2 (HER2)
Xiaoqing Li et al.
ANALYTICAL CHEMISTRY (2018)
Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics
Serban Negoita et al.
CANCER (2018)
An innovative immunosensor for ultrasensitive detection of breast cancer specific carbohydrate (CA 15-3) in unprocessed human plasma and MCF-7 breast cancer cell lysates using gold nanospear electrochemically assembled onto thiolated graphene quantum dots
Mohammad Hasanzadeh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement
David C. Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Molecularly imprinted electrochemical sensor for the point-of-care detection of a breast cancer biomarker (CA 15-3)
Joao G. Pacheco et al.
SENSORS AND ACTUATORS B-CHEMICAL (2018)
Breast cancer biomarker (HER2-ECD) detection using a molecularly imprinted electrochemical sensor
Joao G. Pacheco et al.
SENSORS AND ACTUATORS B-CHEMICAL (2018)
Lung cancer stage-shift following a symptom awareness campaign
Martyn P. T. Kennedy et al.
THORAX (2018)
Patterns and Trends in Cancer Screening in the United States
Ingrid J. Hall et al.
PREVENTING CHRONIC DISEASE (2018)
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
Remy Thomas et al.
FRONTIERS IN IMMUNOLOGY (2018)
Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?
Bibi Kulsoom et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Current trends and emerging diagnostic techniques for lung cancer
Bala Prabhakar et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Graphene nanocomposites modified electrochemical aptamer sensor for rapid and highly sensitive detection of prostate specific antigen
Bo Wei et al.
BIOSENSORS & BIOELECTRONICS (2018)
Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray
Min Wu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2018)
Delayed Sensor Activation Based on Transient Coatings: Biofouling Protection in Complex Biofluids
Victor Ruiz-Valdepenas Montiel et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Diagnostic, prognostic and therapeutic role of CD30 in lymphoma
John Matthew R. Pierce et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial
Yiwey Shieh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
Peter C. Thuss-Patience et al.
LANCET ONCOLOGY (2017)
Future cancer research priorities in the USA: a Lancet Oncology Commission
Elizabeth M. Jaffee et al.
LANCET ONCOLOGY (2017)
Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions
C. A. van der Weyden et al.
BLOOD CANCER JOURNAL (2017)
The effect of CA125 on metastasis of ovarian cancer: old marker new function
Qin Yuan et al.
ONCOTARGET (2017)
Conducting Polymer-Layered Carbon Nanotube as Sensor Interface for Electrochemical Detection of Dacarbazine In-Vitro
M. Satyanarayana et al.
ELECTROCATALYSIS (2017)
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial
Yiwey Shieh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
CANCER SCREENING AND EARLY DETECTION IN THE 21ST CENTURY
Jennifer T. Loud et al.
SEMINARS IN ONCOLOGY NURSING (2017)
The WISDOM Study: breaking the deadlock in the breast cancer screening debate
Laura J. Esserman
NPJ BREAST CANCER (2017)
Recent advances in biosensor development for the detection of cancer biomarkers
V. S. P. K. Sankara Aditya Jayanthi et al.
BIOSENSORS & BIOELECTRONICS (2017)
The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients
Li Zhang et al.
BMC CANCER (2017)
Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers
Vinay Varadan et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Diffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshop
Bachir Taouli et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)
Improving early diagnosis of symptomatic cancer
Willie Hamilton et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Testing for ROS1 in non-small cell lung cancer: a review with recommendations
Lukas Bubendorf et al.
VIRCHOWS ARCHIV (2016)
Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers
Boram Lee et al.
ONCOTARGET (2016)
Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer
Edith A. Perez et al.
JAMA ONCOLOGY (2016)
Change in public awareness of symptoms and perceived barriers to seeing a doctor following Be Clear on Cancer campaigns in England
E. Power et al.
BRITISH JOURNAL OF CANCER (2015)
Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review
R. D. Neal et al.
BRITISH JOURNAL OF CANCER (2015)
Analysis of the intensity of immune cell infiltration and immunoreactivity of RCAS1 in diffuse large B-cell lymphoma of the palatine tonsil and its microenvironment
W. Kazmierczak et al.
CELL AND TISSUE RESEARCH (2015)
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
Junzo Hamanishi et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Wireless Integrated Biosensors for Point-of-Care Diagnostic Applications
Ebrahim Ghafar-Zadeh
SENSORS (2015)
Molecular imaging for cancer diagnosis and surgery
Timon Hussain et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinornas: patient outcome, interplay with morphology and immunophenotype
Arne Warth et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Next-generation Prostate-specific Antigen Test: Ready To Use?
Anders S. Bjartell
EUROPEAN UROLOGY (2013)
EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
Gillian Ellison et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Biomarker Testing for Ovarian Cancer: Clinical Utility of Multiplex Assays
Brian M. Nolen et al.
MOLECULAR DIAGNOSIS & THERAPY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Biomarkers and biosensors for the early diagnosis of lung cancer
Zeynep Altintas et al.
SENSORS AND ACTUATORS B-CHEMICAL (2013)
Selective Immunophenotyping for Diagnosis of B-cell Neoplasms: Immunohistochemistry and Flow Cytometry Strategies and Results
Scott D. Boyd et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2013)
Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets
L. Elliss-Brookes et al.
BRITISH JOURNAL OF CANCER (2012)
PSA velocity and doubling time in diagnosis and prognosis of prostate cancer
Andrew J. Vickers et al.
JOURNAL OF CLINICAL UROLOGY (2012)
EGFR Mutations and Lung Cancer
Gilda da Cunha Santos et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Accuracy of differential diagnosis for pancreatic cancer is improved in the combination of RCAS1 and CEA measurements and cytology in pancreatic juice
Yoshiki Naito et al.
MEDICAL MOLECULAR MORPHOLOGY (2011)
Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer
Michael H. Chapman et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2011)
Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker
Lei Chen et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
S-J Dawson et al.
BRITISH JOURNAL OF CANCER (2010)
Diseases as network perturbations
Antonio del Sol et al.
CURRENT OPINION IN BIOTECHNOLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Principles of Cancer Screening: Lessons From History and Study Design Issues
Jennifer M. Croswell et al.
SEMINARS IN ONCOLOGY (2010)
The association between RCAS1 expression in laryngeal and pharyngeal cancer and its healthy stroma with cancer relapse
Magdalena Dutsch-Wicherek et al.
BMC CANCER (2009)
American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Usha Menon et al.
LANCET ONCOLOGY (2009)
Biosensors for cancer markers diagnosis
Ibtisam E. Tothill
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2009)
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
[Anonymous]
NEOPLASIA (2009)
Benefits and harms of prostate-specific antigen screening for prostate cancer: An evidence update for the US preventive services task force
Kenneth Lin et al.
ANNALS OF INTERNAL MEDICINE (2008)
Screening for prostate cancer: US preventive services task force recommendation statement
ANNALS OF INTERNAL MEDICINE (2008)
Soluble CD22 as a tumor marker for hairy cell leukemia
Kakushi Matsushita et al.
BLOOD (2008)
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
Kazuhide Tsuji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Mining the plasma proteome for cancer biomarkers
Samir M. Hanash et al.
NATURE (2008)
Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18)
Brian A. McCarthy et al.
MOLECULAR MEDICINE (2008)
Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target
Margaret A. Knowles
WORLD JOURNAL OF UROLOGY (2007)
TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis
Monalisa Sur et al.
MODERN PATHOLOGY (2007)
Prostate-specific antigen in the early detection of prostate cancer
Ian M. Thompson et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Dialogue between blastocyst hCG and endometrial LH/hCG receptor: Which role in implantation?
S. Perrier d'Hauterive et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2007)
Molecular PCA3 diagnostics on prostatic fluid
Martijn P. M. Q. van Gis et al.
PROSTATE (2007)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer
A Kumar et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
Serum tumor markers in breast cancer: Are they of clinical value?
MJ Duffy
CLINICAL CHEMISTRY (2006)
Biomarkers in cancer screening, research and detection: present and future: a review
S. Kumar et al.
BIOMARKERS (2006)
Biomarkers in cancer staging, prognosis and treatment selection
JA Ludwig et al.
NATURE REVIEWS CANCER (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Soluble mesothelin-related protein - A blood test for mesothelioma
BWS Robinson et al.
LUNG CANCER (2005)
Radical prostatectomy versus watchful waiting in early prostate cancer
A Bill-Axelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gene expression profiling of breast cancer: A new tumor marker
LJ van't Veer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Tumor markers in breast cancer - European Group on Tumor Markers recommendations
R Molina et al.
TUMOR BIOLOGY (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC)
D Ferrigno et al.
LUNG CANCER (2003)
Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125
NK Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tumor markers in the diagnosis of primary bladder cancer. A systematic review
AS Glas et al.
JOURNAL OF UROLOGY (2003)
The cancer antigen CA125 represents a novel counter receptor for galectin-1
C Seelenmeyer et al.
JOURNAL OF CELL SCIENCE (2003)
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma
EL Mazzaferri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population
W Hofmann et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Prognostic value of serum tumor markers in patients with lung cancer
KD Hatzakis et al.
RESPIRATION (2002)
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology
RC Bast et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Assessment of fibrin-fibrinogen degradation products (Accu-Dx) test in bladder cancer patients
M Topsakal et al.
EUROPEAN UROLOGY (2001)
A proposed role for hCC in clinical obstetrics
JT Kurtzman et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2001)